A System Review and Meta-Analysis of Canaloplasty Outcomes in Glaucoma Treatment in Comparison with Trabeculectomy

Table 2

Meta-analysis outcomes of reductions in IOP and antiglaucoma medications (AGMs) at 6 and 12 months postoperationally.

		IOP reduction (95% CI) mmHg	AGMs, reduction (95% CI)
Standalone canaloplasty	6 months	12.01 (9.77, 14.24)	2.01 (1.51, 2.50)
	12 months	11.38 (9.43, 13.34)	2.16 (1.79, 2.53)
Phacocanaloplasty	6 months	8.32 (5.36, 11.27)	2.03 (1.36, 2.70)
	12 months	8.14 (4.83, 11.46)	2.04 (1.15, 2.92)